In today's Morning Views publication we comment on developments of the following high yield issuers: Playtech, Guala Closures, evoke, Grupo Antolin, Nokia, NES Fircroft, MasOrange, Paprec Group, Biofarma, Vallourec, Forvia (formerly Faurecia), Ineos, Ineos Quattro
In today's Morning Views publication we comment on developments of the following high yield issuers: Mahle, Guala Closures, Playtech, Grupo Antolin, NewDay, Kiloutou, David Lloyd Leisure, Omnia Technologies, Cirsa, evoke, Derichebourg, Seche Environnement, Samvardhana Motherson, Teva
evoke published strong H1/25 results yesterday, with sales up 3% y-o-y and adjusted EBITDA growing 44%. FCF also improved, but remained negative. Net leverage fell 0.7x from FYE 2024 at 5.0x. The company reiterated its FY 2025 guidance. We expect EBITDA growth and further deleveraging in FY 2025.
The Europe HY Trade Book for May 2025 includes current trade recommendations drawn from our European HY coverage universe, along with relative-value scatter plots and tables by industry. We also discuss the US tariff situation and key related impacts.
In today's Morning Views publication we comment on developments of the following high yield issuers: CeramTec, evoke, SPIE, Fedrigoni, Odido, Profine, Infopro Digital, Banijay, Neopharmed, Vedanta Resources, Nemak, CMA CGM, Ineos, Ineos Quattro, Flos B&B Italia (formerly International Design Group)
Summary Marketline's Crown Resorts Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Crown Resorts Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Inv...
A director at Tabcorp Holdings Limited bought 78,500 shares at 0.599AUD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
evoke published its FY 2024 results yesterday, with slightly better performance compared to the full-year trading update released in January 2025. FY 2024 sales grew by 3% y-o-y, while adjusted EBITDA rose 4%. FCF strengthened y-o-y, while reported net leverage was 5.7x, improved from 5.9x as of FYE 2023. We expect the company to deliver EBITDA growth and deleverage in FY 2025.
In today's Morning Views publication we comment on developments of the following high yield issuers: Rekeep, Bite, Arrow Global, Guala Closures, evoke (formerly 888 Holdings), Itelyum Group, Grunenthal, Ontex, Ithaca Energy, Travelodge, TAP, Forvia (formerly Faurecia), Odigeo, CABB, Voyage Care
In this publication, we review the past year and discuss our outlook for the next 12 months. We begin our discussion with the macro factors at play, including GDP forecasts, the geopolitical landscape and our expectations for cost inflation. We also trace the development of primary markets in the European HY space, and give our view on defaults in general as well as for our coverage universe. We then discuss sector trends and expectations, along with earnings development for companies under our ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.